Embolotherapy Market Size |Trends | Europe | 2031

Embolotherapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Embolotherapy Market&nbsp;Size, Share &amp; Trends Analysis Report By Product, By Disease, By End-user, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global embolotherapy market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Embolotherapy is a type of endovascular treatment aiming to block abnormal blood vessels to manage hurt, blood vessel malformations, revascularize organs, and scale back tumors. This blockage of blood vessels is called vascular occlusion.&nbsp;

Stainless steel coils, absorbable gelatin pledges and powder, polyvinyl alcohol foam, ethanol, and glue are the main embolic agents used. In the arterial system, both of these agents operate at various levels; for example, coils are similar to surgical ligation and block medium to small arteries, while liquid agents and particles of smaller diameter block at the level of the arteriolar or capillary bed.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product, Disease and End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/embolotherapy-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Increasing prevalence of chronic diseases

The increasing prevalence of several chronic diseases, including cancer, strokes are expected to drive the global Embolotherapy market during the forecasting period.

For instance, according to the report by the American Cancer Society in 2024, it is estimated that about 41,630 new cases will be diagnosed and about 29,840 people will die of these cancers. Additionally, the percentage of people with liver cancer has steadily been increasing in the last decade.&nbsp;

For people whose cancer is found before it&#39;s spread outside the liver, the 5-year survival rate is about 31%. If liver cancer has spread to other parts of the body, the 5-year survival rate is about 3%.

On the other hand, Strokes remain the fifth-leading cause of death in the United States. Stroke strikes every five minutes. 100,000 people have strokes each year. Thus, the above factors are expected to increase the demand for embolotherapy and are about to drive the market growth.

Stringent regulatory frameworks for product commercialization

Rigorous clinical trials and regulatory hurdles can significantly delay the market entry of new embolization devices. Stringent regulations can lead to higher costs associated with product development and clinical trials.

Segment Analysis

The global embolotherapy market is segmented based on product, disease, end-user and region.

Microspheres segment is expected to dominate the market growth

Microspheres vary in size and composition, allowing them to target a wide range of blood arteries and be employed in a variety of embolization techniques. Because of their versatility, they are an effective treatment for a wide range of disorders. The size and distribution of microspheres can be accurately regulated during embolization. This enables targeted treatment of specific locations while reducing the possibility of unintentional occlusion of healthy veins.&nbsp;

Microspheres effectively prevent blood flow by adhering to the geometry of the target vessel. This provides a more thorough blockage than certain other embolic agents. Thus, the above factors are expected to hold the dominant position in the market share.

<h3>Geographical Analysis</h3>

Asia-Pacific is expected to hold a significant position in the embolotherapy market share 

Asia-Pacific region is expected to hold a significant position in the market share. Chronic diseases such as cancer, peripheral vascular disease, and neurological problems are becoming increasingly prevalent in Asia Pacific countries. These conditions are ideal candidates for embolization procedures, increasing demand for embolization devices and procedures in the region. Governments and commercial healthcare providers in the Asia Pacific are increasing their investments in healthcare infrastructure and modern medical technologies.

Asia Pacific hosts 50 percent of the world&#39;s new cancer cases each year, and deaths caused by cancer in Asia are expected to increase by 36 percent by 2030. According to the World Economic Forum in 2024, it is estimated that Asia accounts for 45% of all global breast cancer cases and 58% of cervical cancer deaths worldwide. Thus, the above factors are expected to hold the region in the dominant position.&nbsp;

<h3>COVID-19 Impact Analysis</h3>

Due to the covid-19 pandemic outbreak, the global embolotherapy market was down in the production and sale segments. The outbreak led to the shutdown of all manufacturing firms, except for masks, sanitizers and ventilators. Hence, the products were manufactured less compared to previous years during the outbreak. Hospitals were overwhelmed with COVID-19 patients, imposing a strain on resources and reducing capacity for additional therapies.

<h3>Market Segmentation</h3>

By Product

<ul>
	<li>Microspheres</li>
	<li>Embolic coils</li>
	<li>Microcatheters</li>
	<li>Guidewires&nbsp;</li>
	<li>Others&nbsp;</li>
</ul>

By Disease

<ul>
	<li>Oncology</li>
	<li>Aneurysm</li>
	<li>Peripheral Vascular Diseases&nbsp;</li>
	<li>Others</li>
</ul>

By End-User

<ul>
	<li>Hospitals</li>
	<li>Ambulatory Surgical Centers</li>
	<li>Others</li>
</ul>

By Region

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>UK</li>
		<li>France</li>
		<li>Italy</li>
		<li>Spain</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>South Korea</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa&nbsp;&nbsp;</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the market include Medtronic Plc, Terumo Medical Corporation, GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Boston Scientific Corporation, Sirtex Medical Limited, Stryker Corporation, Cook Medical and Merit Medical Systems Inc. among others.

<h3>Key Developments</h3>

<ul>
	<li>On October 13, 2023, Merit Medical Systems this week announced the launch of its expanded Maestro microcatheter product line. The Maestro product line features embolotherapy devices, which include Embosphere Microspheres.</li>
	<li>On December 11, 2023, Terumo Medical Corporation launched its new AZUR HydroPack Peripheral Coil System in the United States. The AZUR HydroPack Coil System is a soft, universal-shaped platinum and hydrogel coil designed to find and fill empty space within the vessel.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global embolotherapy market segmentation based on product, disease and end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of embolotherapy market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global embolotherapy market report would provide approximately 53 tables, 47 figures and 176 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by Disease</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing prevalence of chronic diseases</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Stringent regulatory frameworks for product commercialization&nbsp;&nbsp;</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Microspheres*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Embolic coils</li>
		<li>Microcatheters</li>
		<li>Guidewires&nbsp;</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease</li>
			<li>Market Attractiveness Index, By Disease</li>
		</ol>
		</li>
		<li>Oncology*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Aneurysm</li>
		<li>Peripheral Vascular Diseases&nbsp;</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Ambulatory Surgical Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			</ol>
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Medtronic Plc*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Terumo Medical Corporation</li>
		<li>GE HealthCare&nbsp;</li>
		<li>Siemens Healthineers</li>
		<li>Koninklijke Philips N.V.&nbsp;</li>
		<li>Boston Scientific Corporation&nbsp;</li>
		<li>Sirtex Medical Limited&nbsp;</li>
		<li>Stryker Corporation</li>
		<li>Cook Medical&nbsp;</li>
		<li>Merit Medical Systems Inc.&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Embolotherapy Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Embolotherapy Market Value, By Disease, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Embolotherapy Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Embolotherapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Embolotherapy Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Embolotherapy Market Value, By Product, 2022-2031 (US$ Million)

Table 7 Global Embolotherapy Market Value, By Disease, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Embolotherapy Market Value, By Disease, 2022-2031 (US$ Million)

Table 9 Global Embolotherapy Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Embolotherapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Embolotherapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Embolotherapy Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Embolotherapy Market Value, By Product, 2022-2031 (US$ Million)

Table 14 North America Embolotherapy Market Value, By Disease, 2022-2031 (US$ Million)

Table 15 North America Embolotherapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Embolotherapy Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Embolotherapy Market Value, By Product, 2022-2031 (US$ Million)

Table 18 South America Embolotherapy Market Value, By Disease, 2022-2031 (US$ Million)

Table 19 South America Embolotherapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 South America Embolotherapy Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Embolotherapy Market Value, By Product, 2022-2031 (US$ Million)

Table 22 Europe Embolotherapy Market Value, By Disease, 2022-2031 (US$ Million)

Table 23 Europe Embolotherapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Embolotherapy Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Embolotherapy Market Value, By Product, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Embolotherapy Market Value, By Disease, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Embolotherapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Embolotherapy Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East &amp; Africa Embolotherapy Market Value, By Product, 2022-2031 (US$ Million)

Table 30 Middle East &amp; Africa Embolotherapy Market Value, By Disease, 2022-2031 (US$ Million)

Table 31 Middle East &amp; Africa Embolotherapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Medtronic Plc: Overview

Table 33 Medtronic Plc: Product Portfolio

Table 34 Medtronic Plc: Key Developments

Table 35 Terumo Medical Corporation: Overview

Table 36 Terumo Medical Corporation: Product Portfolio

Table 37 Terumo Medical Corporation: Key Developments

Table 38 GE HealthCare : Overview

Table 39 GE HealthCare : Product Portfolio

Table 40 GE HealthCare : Key Developments

Table 41 Siemens Healthineers: Overview

Table 42 Siemens Healthineers: Product Portfolio

Table 43 Siemens Healthineers: Key Developments

Table 44 Koninklijke Philips N.V. : Overview

Table 45 Koninklijke Philips N.V. : Product Portfolio

Table 46 Koninklijke Philips N.V. : Key Developments

Table 47 Boston Scientific Corporation : Overview

Table 48 Boston Scientific Corporation : Product Portfolio

Table 49 Boston Scientific Corporation : Key Developments

Table 50 Sirtex Medical Limited : Overview

Table 51 Sirtex Medical Limited : Product Portfolio

Table 52 Sirtex Medical Limited : Key Developments

Table 53 Stryker Corporation: Overview

Table 54 Stryker Corporation: Product Portfolio

Table 55 Stryker Corporation: Key Developments

Table 56 Cook Medical : Overview

Table 57 Cook Medical : Product Portfolio

Table 58 Cook Medical : Key Developments

Table 59 Merit Medical Systems Inc.: Overview

Table 60 Merit Medical Systems Inc.: Product Portfolio

Table 61 Merit Medical Systems Inc.: Key Developments

List of Figures

Figure 1 Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Embolotherapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 3 Global Embolotherapy Market Share, By Disease, 2023 &amp; 2031 (%)

Figure 4 Global Embolotherapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 5 Global Embolotherapy Market Share, By Region, 2023 &amp; 2031 (%)

Figure 6 Global Embolotherapy Market Y-o-Y Growth, By Product, 2023-2031 (%)

Figure 7 Microspheres Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 8 Embolic coils Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 9 Microcatheters Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 10 Guidewires&nbsp; Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 11 Others Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 12 Global Embolotherapy Market Y-o-Y Growth, By Disease, 2023-2031 (%)

Figure 13 Oncology Disease in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 14 Aneurysm Disease in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 15 Peripheral Vascular Diseases&nbsp; Disease in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 16 Others Disease in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 17 Global Embolotherapy Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 18 Hospitals End-User in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 19 Ambulatory Surgical Centers End-User in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 20 Others End-User in Global Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 21 Global Embolotherapy Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 22 North America Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 23 Asia-Pacific Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 24 Europe Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 25 South America Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 26 Middle East and Africa Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 27 North America Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 28 North America Embolotherapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 29 North America Embolotherapy Market Share, By Disease, 2023 &amp; 2031 (%)

Figure 30 North America Embolotherapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 31 North America Embolotherapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 32 South America Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 33 South America Embolotherapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 34 South America Embolotherapy Market Share, By Disease, 2023 &amp; 2031 (%)

Figure 35 South America Embolotherapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 36 South America Embolotherapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 37 Europe Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 38 Europe Embolotherapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 39 Europe Embolotherapy Market Share, By Disease, 2023 &amp; 2031 (%)

Figure 40 Europe Embolotherapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 41 Europe Embolotherapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 42 Asia-Pacific Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 43 Asia-Pacific Embolotherapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 44 Asia-Pacific Embolotherapy Market Share, By Disease, 2023 &amp; 2031 (%)

Figure 45 Asia-Pacific Embolotherapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 46 Asia-Pacific Embolotherapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 47 Middle East &amp; Africa Embolotherapy Market Value, 2022-2031 (US$ Million)

Figure 48 Middle East &amp; Africa Embolotherapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 49 Middle East &amp; Africa Embolotherapy Market Share, By Disease, 2023 &amp; 2031 (%)

Figure 50 Middle East &amp; Africa Embolotherapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 51 Medtronic Plc: Financials

Figure 52 Terumo Medical Corporation: Financials

Figure 53 GE HealthCare : Financials

Figure 54 Siemens Healthineers: Financials

Figure 55 Koninklijke Philips N.V. : Financials

Figure 56 Boston Scientific Corporation : Financials

Figure 57 Sirtex Medical Limited : Financials

Figure 58 Stryker Corporation: Financials

Figure 59 Cook Medical : Financials

Figure 60 Merit Medical Systems Inc.: Financials

Embolotherapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Embolization Coil Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 08

Starting from

Vascular Embolization Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 28

Starting from

Refrigeration Oil Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 05

Starting from